ArticleQuantitative imaging in medicine and surgery2023
A Bi-LSTM and multihead attention-based model incorporating radiomics signatures and radiological features for differentiating the main subtypes of lung adenocarcinoma.
Article in Quantitative imaging in medicine and surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Using natural language processing to analyze unstructured patient-reported outcomes data derived from electronic health records for cancer populations: a systematic review.Expert review of pharmacoeconomics & outcomes research · 2024Pooled it
- CT-based radiomics and clinical characteristics for predicting bone metastasis in lung adenocarcinoma patients.Translational lung cancer research · 2024Article
- Research and implementation of multi-disease diagnosis on chest X-ray based on vision transformer.Quantitative imaging in medicine and surgery · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The radiological features of computed tomography (CT) images and the sequence of radiomics signatures in continuous slices of lung CT lesions are helpful in identifying subtypes of lung adenocarcinoma. A model based on bidirectional long short-term memory (Bi-LSTM) and multihead attention can learn the rules of this sequence well. Methods: In this study, 421 patients with 427 lesions confirmed as adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) or invasive adenocarcinoma (IAC) were recruited from three hospitals. The radiomics signatures of the identified lesion regions in each CT image were extracted using 'PyRadiomics' software, and the corresponding radiological features were subsequently documented and collected. Then, the top 100 features were extracted by the minimum redundancy maximum relevance (mRMR) feature ranking method. A model based on the radiological and imaging features was established to classify the lesions using Bi-LSTM and multihead attention. The diagnostic performance of the model was measured by the area under the curve (AUC) of the receiver operating characteristic (ROC). Results: The model combined radiological features and radiomics signatures. The AUCs of the model in the training, testing, and validation groups were 0.985, 0.94 and 0.981, respectively, and the accuracy was 0.92, 0.976 and 0.91, respectively. In addition, we trained two other models [convolutional neural network (CNN) + multihead attention, long short-term memory (LSTM) + multihead attention] and compared them using the testing dataset. The precision of the two models was 0.89 and 0.88, respectively, and the accuracy was 0.88 and 0.87, respectively. Conclusions: Bi-LSTM and multihead attention based on radiomics signatures and radiological features provide a way to distinguish AIS, MIA, and IAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.